[go: up one dir, main page]

AU2617288A - Pharmaceutical formulations for transdermal administration - Google Patents

Pharmaceutical formulations for transdermal administration

Info

Publication number
AU2617288A
AU2617288A AU26172/88A AU2617288A AU2617288A AU 2617288 A AU2617288 A AU 2617288A AU 26172/88 A AU26172/88 A AU 26172/88A AU 2617288 A AU2617288 A AU 2617288A AU 2617288 A AU2617288 A AU 2617288A
Authority
AU
Australia
Prior art keywords
pharmaceutical formulations
transdermal administration
transdermal
administration
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26172/88A
Inventor
Luciano Cocchi
Simos Contos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Also Laboratori SAS Di Dr P Sorbini and C
Original Assignee
Also Laboratori SAS Di Dr P Sorbini and C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Also Laboratori SAS Di Dr P Sorbini and C filed Critical Also Laboratori SAS Di Dr P Sorbini and C
Publication of AU2617288A publication Critical patent/AU2617288A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU26172/88A 1987-11-03 1988-10-26 Pharmaceutical formulations for transdermal administration Abandoned AU2617288A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22501/87 1987-11-03
IT22501/87A IT1223343B (en) 1987-11-03 1987-11-03 PHARMACEUTICAL FORMULATIONS FOR TRANSDERMAL ADMINISTRATION

Publications (1)

Publication Number Publication Date
AU2617288A true AU2617288A (en) 1989-06-01

Family

ID=11197124

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26172/88A Abandoned AU2617288A (en) 1987-11-03 1988-10-26 Pharmaceutical formulations for transdermal administration

Country Status (3)

Country Link
AU (1) AU2617288A (en)
IT (1) IT1223343B (en)
WO (1) WO1989004179A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1243342B (en) * 1990-07-13 1994-06-10 Farcon Ag ORAL PHARMACEUTICAL COMPOSITIONS FOR LIQUID ANTI-INFLAMMATORY ACTIVITIES
DE4405898A1 (en) * 1994-02-18 1995-08-24 Schering Ag Transdermal therapeutic systems containing sex steroids
AU724308B2 (en) * 1994-02-18 2000-09-14 Schering Aktiengesellschaft Transdermal therapeutic systems that contain sex steroids
KR19990026792A (en) * 1997-09-26 1999-04-15 김윤 Matrix Patches Containing Diclofenac Diethylammonium Salt
DE10053397A1 (en) 2000-10-20 2002-05-02 Schering Ag Use of a dopaminergic active ingredient for the treatment of dopaminerg treatable diseases
DE10228680A1 (en) * 2002-06-27 2004-01-22 Holden Development Limited, Tortola Basis for transdermal formulations (PTF)
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
AU2008326309C1 (en) 2007-11-21 2015-03-12 Decode Genetics Ehf Biaryl PDE4 inhibitors for treating pulmonary and cardiovascular disorders
NZ586120A (en) 2008-01-11 2012-07-27 Albany Molecular Res Inc (1-azinone) -substituted pyridoindoles as mch antagonists
WO2010059836A1 (en) 2008-11-20 2010-05-27 Decode Genetics Ehf Substituted aza-bridged bicyclics for cardiovascular and cns disease
US8673931B2 (en) 2009-01-26 2014-03-18 Abraham Fisher Bicyclic heterocyclic spiro compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
LU84514A1 (en) * 1982-12-09 1984-10-22 Oreal STABLE COMPOSITION FOR LOCAL CORTICOTHERAPY CONTAINING HYDROCORTISONE IN SOLUBILIZED CONDITIONS
DE3333240A1 (en) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen MEDIUM FOR TRANSDERMAL APPLICATION OF MEDICINAL PRODUCTS
GB8331037D0 (en) * 1983-11-21 1983-12-29 May & Baker Ltd Compositions of matter

Also Published As

Publication number Publication date
IT1223343B (en) 1990-09-19
IT8722501A0 (en) 1987-11-03
WO1989004179A1 (en) 1989-05-18

Similar Documents

Publication Publication Date Title
AU5087290A (en) Transmembrane formulations for drug administration
AU4243289A (en) Pharmaceutical formulations
ZA892321B (en) Pharmaceutical composition for systemic transdermal administration
AU8298287A (en) Transdermal contraceptive formulations
AU2707788A (en) Sustained release pharmaceutical composition
AU6893287A (en) Sustained release pharmaceutical preparation
AU5124790A (en) Improvements in or relating to devices for administration of drugs or the like
AU1235088A (en) Pharmaceutical plaster
AU7756487A (en) Pharmaceutical formulations
AU5157590A (en) Pharmaceutical compositions for oral administration
AU2049388A (en) Transdermal administration using benzyl alcohol
AU2228888A (en) Aqueous pharmaceutical preparation for oral administration
AU1925488A (en) Pharmaceutical compositions
AU2617288A (en) Pharmaceutical formulations for transdermal administration
AU2027288A (en) Erythromycin formulations for oral administration
AU2201888A (en) Pharmaceutical combination
AU2345988A (en) Pharmaceutical composition for piperidinoalkanol-decongestant combination
AU2346088A (en) Pharmaceutical composition for piperidinoalkanol derivatives
AU1928988A (en) Pharmaceutical compositions
AU2065588A (en) Pharmaceutical preparations for external use
AU3041789A (en) Pharmaceutical formulations with controlled drug release
AU1635588A (en) Pharmaceutical compositions
GB8712240D0 (en) Pharmaceutical formulation
AU2649288A (en) Transdermal absorptive drug formulation
AU1507688A (en) Pharmaceutical compositions